Matthew 25 Management Corp’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Matthew 25 Management Corp's LLY Position: Q2 2026 in Review
Matthew 25 Management Corp reduced its Eli Lilly (LLY) stake by 11% in Q2 2026, selling an estimated $3.07M and leaving 24,500 shares worth $29.4M. The position accounts for 8.51% of the portfolio, ranked #3.
Matthew 25 Management Corp first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Matthew 25 Management Corp held 24,500 shares of Eli Lilly worth $29.4M as of Q2 2026.
- Matthew 25 Management Corp sold 3,000 Eli Lilly shares in Q2 2026, an estimated $3.07M.
- Eli Lilly made up 8.51% of Matthew 25 Management Corp's portfolio in Q2 2026, its #3 holding.
- Matthew 25 Management Corp first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Matthew 25 Management Corp's 13F filing for Q2 2026, filed 14 Aug 2026.